Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer
- PMID: 1712638
Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer
Abstract
Numerous factors that can influence the proliferation and differentiation in vitro of cells at various stages of hematopoiesis have been identified, but the mechanisms used by stromal cells to regulate the cycling status of the most primitive human hematopoietic cells are still poorly understood. Previous studies of long-term cultures (LTC) of human marrow have suggested that cytokine-induced variations in stromal cell production of one or more stimulators and inhibitors of hematopoiesis may be important. To identify the specific regulators involved, we performed Northern analyses on RNA extracted from human marrow LTC adherent layers, or stromal cell types derived from or related to those present in the adherent layer. These analyses showed marked increases in interleukin-1 beta (IL-1 beta), IL-6, and granulocyte colony-stimulating factor (G-CSF) mRNA levels within 8 hours after treatments that lead to the activation within 2 days of primitive hematopoietic progenitors in such cultures. Increases in granulocyte-macrophage (GM)-CSF and M-CSF mRNA were also sometimes seen. Bioassays using cell lines responsive to G-CSF, GM-CSF, and IL-6 showed significant elevation in growth factor levels 24 hours after IL-1 beta stimulation. Neither IL-3 nor IL-4 mRNA was detectable at any time. In contrast, transforming growth factor-beta (TGF-beta) mRNA and nanogram levels of TGF-beta bioactivity in the medium were detected at all times in established LTC, and these levels were not consistently altered by any of the manipulations that stimulated hematopoietic growth factor production and primitive progenitor cycling. We also found that addition of anti-TGF-beta antibody could prolong or reactivate primitive progenitor proliferation when added to previously stimulated or quiescent cultures, respectively. Together, these results indicate a dominant negative regulatory role of endogenously produced TGF-beta in unperturbed LTC, with activation of primitive hematopoietic cells being achieved by mechanisms that stimulate stromal cells to produce G-CSF, GM-CSF, and IL-6. Given the similarities between the LTC system and the marrow microenvironment, it seems likely that the control of human stem cell activation in vivo may involve similar variations in the production of these factors by stromal cells.
Similar articles
-
Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures.Blood. 1991 Feb 1;77(3):493-9. Blood. 1991. PMID: 1703795
-
Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.J Cell Physiol. 1992 Jul;152(1):199-206. doi: 10.1002/jcp.1041520125. J Cell Physiol. 1992. PMID: 1377699
-
Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells.Blood. 1991 Aug 1;78(3):666-72. Blood. 1991. PMID: 1713512
-
Molecular analysis of primitive hematopoietic cell proliferation control mechanisms.Ann N Y Acad Sci. 1991;628:298-306. doi: 10.1111/j.1749-6632.1991.tb17260.x. Ann N Y Acad Sci. 1991. PMID: 1712556 Review.
-
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.Cell Mol Life Sci. 2018 Apr;75(8):1363-1376. doi: 10.1007/s00018-017-2724-5. Epub 2017 Dec 7. Cell Mol Life Sci. 2018. PMID: 29218601 Free PMC article. Review.
Cited by
-
Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.Cytotechnology. 1999 Jul;30(1-3):227-34. doi: 10.1023/A:1008085932764. Cytotechnology. 1999. PMID: 19003372 Free PMC article.
-
Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.Br J Cancer. 1997;75(5):656-9. doi: 10.1038/bjc.1997.117. Br J Cancer. 1997. PMID: 9043020 Free PMC article.
-
CDK-inhibitor independent cell cycle progression in an experimental haematopoietic stem cell leukaemia despite unaltered Rb-phosphorylation.Br J Cancer. 1999 Nov;81(5):808-13. doi: 10.1038/sj.bjc.6690768. Br J Cancer. 1999. PMID: 10555750 Free PMC article.
-
Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12015-9. doi: 10.1073/pnas.90.24.12015. Proc Natl Acad Sci U S A. 1993. PMID: 8265663 Free PMC article.
-
BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.J Neurosci. 2009 Nov 25;29(47):14932-41. doi: 10.1523/JNEUROSCI.2769-09.2009. J Neurosci. 2009. PMID: 19940189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials